European Journal of Cancer
Volume 40, Issue 4 , Pages 487-493 , March 2004

Using loco-regional recurrence as an indicator of the quality of breast cancer treatment

  • M.F. Ernst

      Affiliations

    • Department of Surgery, St. Elisabeth Hospital, PO Box 90151, 5000 LC Tilburg, The Netherlands
    • Department of Surgery, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author at current address (affiliation b). Tel.: +31-20-566-2766; fax: +31-20-691-4858
    • ,
  • A.C. Voogd

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South, PO Box 231, 5600 AE Eindhoven, The Netherlands
    • Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • J.-W.W. Coebergh

      Affiliations

    • Eindhoven Cancer Registry, Comprehensive Cancer Centre South, PO Box 231, 5600 AE Eindhoven, The Netherlands
    • Department of Public Health, Erasmus University Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    • ,
  • P.M. Poortmans

      Affiliations

    • Department of Radiotherapy, Dr. Bernard Verbeeten Instituut, PO Box 90120, 5000 LA Tilburg, The Netherlands
    • ,
  • J.A. Roukema

      Affiliations

    • Department of Surgery, St. Elisabeth Hospital, PO Box 90151, 5000 LC Tilburg, The Netherlands

Received 28 July 2003 ,Revised 2 October 2003 ,Accepted 21 October 2003.

References 

  1. Veronesi U, Saccozzi R, Del Vecchio M, et al.  Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N. Engl. J. Med. 1981;305:6–11
  2. Sarrazin D, Lê M, Rouëssé J, et al.  Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less. Cancer. 1984;53:1209–1213
  3. Fisher B, Bauer M, Margolese R, et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N. Engl. J. Med. 1985;312:865–873
  4. Voogd AC, Repelaer van Driel OJ, Roumen RMH, Crommelin MA, van Beek MWPM, Coebergh JWW. Changing attitudes towards breast-conserving treatment of early breast cancer in the south-eastern Netherlands (results of a survey among surgeons and a registry-based analysis of patterns of care). Eur. J. Surg. Oncol. 1997;23:134–138
  5. Calle R, Vilcoq JR, Zafrani B, Vielh P, Fourquet A. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1986;12:873–878
  6. van Limbergen E, van der Bogaert W, van der Schueren E, et al.  Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patients and treatment parameters and local control. Radiother. Oncol. 1987;8:1–9
  7. Kurtz JM, Spitalier J-M, Amalric R, et al.  Mammary recurrences in women younger than forty. Int. J. Radiat. Oncol. Biol. Phys. 1988;15:271–276
  8. Stotter AT, McNeese MD, Ames FC, et al.  Predicting the rate and extent of locoregional failure after conservation therapy for early breast cancer. Cancer. 1989;64:2217–2225
  9. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB. Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer. 1984;53:1049–1057
  10. Osteen RT, Connolly JL, Recht A, Silver B, Schnitt SJ, Harris JR. Identification of patients at high risk of local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch. Surg. 1987;122:1248–1252
  11. Kurtz JM, Jacquemier J, Amalric R, et al.  Risk factors for local recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 1990;65:1867–1878
  12. Fourquet A, Campana F, Zafrani B, et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer (a 25-year follow-up). Int. J. Radiat. Oncol. Biol. Phys. 1989;17:719–725
  13. In:  Hermanek P,  Sobin LH editor. UICC TNM Classification of Malignant Tumours. Berlin: Springer-Verlag; 1987;
  14. Clarke DH, Lê MG, Sarrazin D, et al.  Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy (experience of the Institut Gustave-Roussy). Int. J. Radiat. Oncol. Biol. Phys. 1985;11:137–145
  15. Kurtz JM, Amalric R, Delouche G, Pierquin B, Roth J, Spitalier J-M. The second ten years (long-term risks of breast conservation in early breast cancer). Int. J. Radiat. Oncol. Biol. Phys. 1987;13:1327–1332
  16. Grosse A, Schreer I, Frischbier H-J, Maass H, Loening T, Bahnsen J. Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up. Int. J. Radiat. Oncol. Biol. Phys. 1997;38:761–767
  17. Rutgers EJ. Quality control in the locoregional treatment of breast cancer. Eur. J. Cancer. 2001;37:447–453
  18. Golledge J, Wiggins JE, Callam MJ. Effect of surgical subspecialization on breast cancer outcome. Br. J. Surg. 2000;87:1420–1425
  19. Van Tienhoven G, van Bree NA, Mijnheer BJ, Bartelink H. Quality assurance of the EORTC trial 22881/10882 (“assessment of the role of the booster dose in breast conserving therapy”: the dummy run. EORTC Radiotherapy Cooperative Group). Radiother. Oncol. 1991;22:290–298
  20. Bartelink H, Horiot JC, Poortmans P, et al.  Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 2001;345:1378–1387
  21. Elkhuizen PH, van Slooten HJ, Clahsen PC, et al.  High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy; a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J. Clin. Oncol. 2000;18:1075–1083
  22. Bucholz TA, Tucker SL, Erwin J, et al.  Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J. Clin. Oncol. 2001;19:2240–2246
  23. Ernst MF, Voogd AC, Coebergh JWW, Repelaer van Driel OJ, Roukema JA. The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery (a population-based study in Southeast Netherlands). Eur. J. Cancer. 2001;37:2435–2440
  24. Nattinger AB, Hoffmann RG, Kneusel RT, Shapira MM. Relation between appropriateness of primary therapy for early stage breast carcinoma and increased use of breast-conserving surgery. Lancet. 2000;356:1148–1153
  25. Morrow M, White J, Moughan J, et al.  Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J. Clin. Oncol. 2001;19:2254–2262
  26. Overgaard M, Hansen PS, Overgaard J, et al.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N. Engl. J. Med. 1997;337:949–955
  27. Ragaz J, Jackson SM, Le N, et al.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 1997;337:956–962
  28. Fredriksson I, Liljegren G, Arnesson LG, et al.  Time trends in the results of breast conservation in 4694 women. Eur. J. Cancer. 2001;37:1537–1544
  29. Liljegren G, Holmberg L, Bergh J, et al.  10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer (a randomized trial). J. Clin. Oncol. 1999;17:2326–2333
  30. Clark RM, Whelan T, Levine M, et al.  Randomized clinical trial of breastirradiation following lumpectomy and axillary dissection for node-negative breast cancer. J. Natl. Cancer Inst. 1994;86:717–722
  31. Fisher B, Anderson S, Redmond C, Wolmark N, Wickerham DL, Cronin WM. Re-analysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1995;333:1456–1461
  32. Voogd AC, Nielsen M, Peterse JL, et al.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer (pooled results of two large European randomized trials). J. Clin. Oncol. 2001;19:1688–1697

PII: S0959-8049(03)00924-9

doi: 10.1016/j.ejca.2003.10.014

European Journal of Cancer
Volume 40, Issue 4 , Pages 487-493 , March 2004

Article Tools

* Image Usage & Resolution